Daniel Bittner
German Center for Neurodegenerative Diseases
9 Papers
8 Citations
Daniel Bittner is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Cognitive decline & Medicine. The author has an hindex of 7, co-authored 9 publications.
Chat about Author
Papers
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
Nicolai Franzmeier,Emrah Düzel,Frank Jessen,Frank Jessen,Katharina Buerger,Katharina Buerger,Johannes Levin,Johannes Levin,Marco Duering,Martin Dichgans,Martin Dichgans,Christian Haass,Christian Haass,Marc Suárez-Calvet,Marc Suárez-Calvet,Anne M. Fagan,Katrina L. Paumier,Tammie L.S. Benzinger,Colin L. Masters,John C. Morris,Robert Perneczky,Daniel Janowitz,Cihan Catak,Steffen Wolfsgruber,Steffen Wolfsgruber,Michael Wagner,Michael Wagner,Stefan J. Teipel,Stefan J. Teipel,Ingo Kilimann,Ingo Kilimann,Alfredo Ramirez,Alfredo Ramirez,Martin N. Rossor,Mathias Jucker,Jasmeer P. Chhatwal,Annika Spottke,Annika Spottke,Henning Boecker,Henning Boecker,Frederic Brosseron,Frederic Brosseron,Peter Falkai,Peter Falkai,Klaus Fliessbach,Klaus Fliessbach,Michael T. Heneka,Michael T. Heneka,Christoph Laske,Christoph Laske,Peter J. Nestor,Peter J. Nestor,Oliver Peters,Oliver Peters,Manuel Fuentes,Felix Menne,Felix Menne,Josef Priller,Josef Priller,Eike Jakob Spruth,Eike Jakob Spruth,Christiana Franke,Christiana Franke,Anja Schneider,Anja Schneider,Barbara Kofler,Barbara Kofler,Christine Westerteicher,Christine Westerteicher,Oliver Speck,Jens Wiltfang,Jens Wiltfang,Jens Wiltfang,Claudia Bartels,Miguel Ángel Araque Caballero,Coraline D. Metzger,Daniel Bittner,Michael W. Weiner,Jae-Hong Lee,Stephen Salloway,Adrian Danek,Adrian Danek,Alison Goate,Peter R. Schofield,Peter R. Schofield,Randall J. Bateman,Michael Ewers +86 more
TL;DR: Franzmeier et al. show that greater left frontal hub connectivity within the fronto-parietal control network is associated with greater resilience of cognitive performance during the early stages of autosomal dominant and sporadic Alzheimer’s disease.
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.
Nicolai Franzmeier,Jinyi Ren,Alexander Damm,Gemma Monté-Rubio,Mercè Boada,Agustín Ruiz,Alfredo Ramirez,Alfredo Ramirez,Frank Jessen,Frank Jessen,Emrah Düzel,Octavio Rodríguez Gómez,Tammie L.S. Benzinger,Alison Goate,Celeste M. Karch,Anne M. Fagan,Eric McDade,Katharina Buerger,Katharina Buerger,Johannes Levin,Johannes Levin,Marco Duering,Martin Dichgans,Martin Dichgans,Marc Suárez-Calvet,Marc Suárez-Calvet,Marc Suárez-Calvet,Christian Haass,Christian Haass,Brian A. Gordon,Yen Ying Lim,Colin L. Masters,Daniel Janowitz,Cihan Catak,Steffen Wolfsgruber,Steffen Wolfsgruber,Michael Wagner,Michael Wagner,Esther Milz,Sonia Moreno-Grau,Stefan J. Teipel,Michel J. Grothe,Ingo Kilimann,Martin N. Rossor,Nick C. Fox,Christoph Laske,Christoph Laske,Jasmeer P. Chhatwal,Peter Falkai,Robert Perneczky,Jae-Hong Lee,Annika Spottke,Annika Spottke,Henning Boecker,Henning Boecker,Frederic Brosseron,Frederic Brosseron,Klaus Fliessbach,Klaus Fliessbach,Michael T. Heneka,Michael T. Heneka,Peter J. Nestor,Peter J. Nestor,Oliver Peters,Oliver Peters,Manuel Fuentes,Manuel Fuentes,Felix Menne,Felix Menne,Josef Priller,Josef Priller,Eike Jakob Spruth,Eike Jakob Spruth,Christiana Franke,Christiana Franke,Anja Schneider,Anja Schneider,Christine Westerteicher,Christine Westerteicher,Oliver Speck,Jens Wiltfang,Jens Wiltfang,Jens Wiltfang,Claudia Bartels,Miguel Ángel Araque Caballero,Miguel Ángel Araque Caballero,Coraline D. Metzger,Daniel Bittner,Stephen Salloway,Adrian Danek,Jason Hassenstab,Igor Yakushev,Peter R. Schofield,Peter R. Schofield,John C. Morris,Randall J. Bateman,Michael Ewers +96 more
TL;DR: It is suggested that BDNF Val66Met is selectively associated with a higher vulnerability of hippocampus-frontal connectivity to primary AD pathology, resulting in greater AD-related cognitive impairment.
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume
Emrah Düzel,Emrah Düzel,Emrah Düzel,David Berron,David Berron,Hartmut Schütze,Hartmut Schütze,Arturo Cardenas-Blanco,Arturo Cardenas-Blanco,Coraline D. Metzger,Coraline D. Metzger,Matthew J. Betts,Gabriel Ziegler,Gabriel Ziegler,Yi Chen,Yi Chen,Laura Dobisch,Daniel Bittner,Wenzel Glanz,Martin Reuter,Annika Spottke,Janna Rudolph,Frederic Brosseron,Katharina Buerger,Daniel Janowitz,Klaus Fliessbach,Michael T. Heneka,Christoph Laske,Christoph Laske,Martina Buchmann,Martina Buchmann,Peter J. Nestor,Oliver Peters,Oliver Peters,Dominik Diesing,Siyao Li,Josef Priller,Eike Jakob Spruth,Slawek Altenstein,Alfredo Ramirez,Anja Schneider,Barbara Kofler,Oliver Speck,Stefan J. Teipel,Ingo Kilimann,Martin Dyrba,Jens Wiltfang,Jens Wiltfang,Claudia Bartels,Claudia Bartels,Steffen Wolfsgruber,Michael Wagner,Frank Jessen +52 more
TL;DR: The association between cerebrospinal fluid biomarkers of Alzheimer's disease, neural novelty responses, and brain volume in predementia old age is examined.
44
CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
TL;DR: CSF-Neurofilament light chain and CSF-Progranulin seem to be promising biomarkers for FTD, the latter predominantly for assumed TDP43-mediated FTD.
NAC changes the course of cerebral small vessel disease in SHRSP and reveals new insights for the meaning of stases - a randomized controlled study
Celine Z. Bueche,Cornelia Garz,Siegfried Kropf,Daniel Bittner,Wenjie Li,Michael Goertler,Hans-Jochen Heinze,Klaus G. Reymann,Holger Braun,Stefanie Schreiber,Stefanie Schreiber +10 more
TL;DR: NAC reduces the frequency of thromboses and infarcts to the expense of an increase of small microbleeds in a rat model of microangiopathic cerebrovascular disease and reveals that stases are mainly caused by endothelial injuries and restricted thromBoses.